期刊文献+

孕中期血浆n-6多不饱和脂肪酸水平与妊娠期糖尿病的关联 被引量:1

Association of plasma n-6 polyunsaturated fatty acids with gestational diabetes mellitus in the second trimester
原文传递
导出
摘要 目的探讨中国西南地区孕妇孕中期血浆n-6多不饱和脂肪酸(polyunsaturated fatty acids,PUFAs)水平与妊娠期糖尿病(gestational diabetes mellitus,GDM)的关联。方法本研究基于同济-双流出生队列,于2017―2019年在成都市双流区妇幼保健院围产保健门诊纳入18~40岁的6143名单胎妊娠孕妇。通过问卷调查收集孕妇基本信息和孕期健康状况,并对其进行体格测量和血液样本收集。根据孕24~28周孕妇75 g口服葡萄糖耐量试验(oral glucose tolerance test,OGTT)结果,选取269名符合GDM诊断标准的孕妇作为病例组。在非GDM的孕妇中按照孕妇年龄(±3岁)、基线孕周(±4周)进行1∶2匹配,选取538名非GDM孕妇作为对照组。采用气相色谱-质谱联用的方法检测孕妇孕中期血浆多种n-6 PUFAs水平。采用多变量校正的条件Logistic回归分析模型评估孕中期血浆各n-6 PUFAs类别和总n-6 PUFAs与GDM患病风险的关联,并利用错误发现率(false discovery rate,FDR)法校正多重检验。采用敏感性分析探讨其稳健性。结果807名研究对象的年龄为(27.8±3.9)岁,孕周为(24.8±1.1)周,孕前BMI为(21.5±3.1)kg/m^(2)。孕中期血浆亚油酸(linoleic acid,LA)、γ-亚油酸(gamma-linolenic acid,GLA)、二十碳二烯酸(eicosadienoic acid,EDA)和花生四烯酸(arachidonic acid,AA)水平每增加一个标准差,GDM的患病风险的OR值分别为0.83(95%CI:0.69~0.99,P=0.039)、0.82(95%CI:0.69~0.99,P=0.037)、0.63(95%CI:0.50~0.79,P<0.001)和1.20(95%CI:1.02~1.42,P=0.032),而多重校正后LA、GLA和AA与GDM患病风险关联无统计学意义(均有P>0.05)。敏感性分析结果显示EDA与GDM患病风险的关联稳定。结论孕中期血浆n-6 PUFAs中EDA与GDM患病风险有关,此结论需进一步在大样本人群中进行验证。 Objective The study aims to explore the association of plasma n-6 polyunsaturated fatty acids(PUFAs)with gestational diabetes mellitus(GDM)in the second trimester of pregnant women in southwest China.Methods In the Tongji-Shuangliu Birth Cohort,6143 women with a singleton pregnancy(aged 18-40 years)were enrolled at the clinics of perinatal care in the Shuangliu Maternal and Child Health Care Hospital in Chengdu from 2017 to 2019.Basic information of participants was collected by questionnaire and physical examinations were performed at enrollment,and blood samples were collected in the second trimester.A total of 269 pregnant women were diagnosed as having GDM based on the 75 g oral glucose tolerance test during 24-28 weeks.The GDM cases were matched individually to 538 non-GDM controls at a 1∶2 ratio on maternal age(±3 years)and baseline gestational week(±4 weeks).Plasma n-6 PUFAs were determined by gas chromatography-mass spectrometry in the second trimester.The associations of individual n-6 PUFAs and total n-6 PUFAs with GDM were evaluated using multivariable conditional Logistic regression models,and false discovery rate(FDR)was used for the correction of multiple comparison.Sensitivity analysis was used to test the robustness of the associations.Results Of the 807 participants,maternal age was(27.8±3.9)years,and gestational age was(24.8±1.1)weeks,and pre-pregnancy BMI was(21.5±3.1)kg/m^(2).Odds ratios(ORs)for GDM in relation to each 1-SD increase in plasma linoleic acid(LA),gamma-linolenic acid(GLA),eicosadienoic acid(EDA),and arachidonic acid(AA)were 0.83(95%CI:0.69-0.99,P=0.039),0.82(95%CI:0.69-0.99,P=0.037),0.63(95%CI:0.50-0.79,P<0.001)and 1.20(95%CI:1.02-1.42,P=0.032),respectively;however,the associations of LA,GLA,and AA with GDM became not significant after FDR correction(all P>0.05).The association of EDA with GDM were robust in sensitivity analyses.Conclusion Plasma EDA in the second trimester was associated with GDM,which needs to be further validated in other populations.
作者 王凡 刘艳 王意 叶怡翔 黄以超 陈达 潘雄飞 潘安 WANG Fan;LIU Yan;WANG Yi;YE Yi-xiang;HUANG Yi-chao;CHEN Da;PAN Xiong-fei;PAN An(Department of Epidemiology and Biostatistics,School of Public Health,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Obstetrics and Gynecology,Shuangliu Maternal and Child Health Hospital of Chengdu,Chengdu 610200,China;Department of Hygienic Toxicology,School of Public Health,Anhui Medical University,Hefei 230032,China;College of Environmental Sciences,Jinan University,Guangzhou 510632,China)
出处 《中华疾病控制杂志》 CAS CSCD 北大核心 2022年第4期417-422,共6页 Chinese Journal of Disease Control & Prevention
基金 国家自然科学基金(81773517) 四川省卫生健康委员会科研课题(19PJ182) 中央高校基本科研业务费专项资金(2019kfyXKJC052) 博士后科学基金(2017M622457)。
关键词 n-6多不饱和脂肪酸 妊娠期糖尿病 病例对照研究 N-6 polyunsaturated fatty acids Gestational diabetes mellitus Case-control study
  • 相关文献

参考文献1

二级参考文献46

  • 1Kahn CR.Joslin糖尿病学[M].14版.潘长玉,主译.北京:人民卫生出版社,2005:550-552.
  • 2中华医学会妇产科学分会产科学组,中华医学会围产医学分会妊娠合并糖尿病协作组.妊娠合并糖尿病临床诊断与治疗推荐指南(草案)[J].中华妇产科杂志,2007,42:426-428.
  • 3中华人民共和国国家卫生部.WS331-2011妊娠期糖尿病诊断[s]北京:中华人民共和国国家卫生部,2011.
  • 4International Association of Diabetes and Pregnancy 3tudy Groups Consensus Panel,Metzger BE,Gabbe SG, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy[J].Diabetes Care,2010,33:676-682.
  • 5International Diabetes Federation. Global Guideline on Pregnancy and Diabetes[S].Brussels: International Diabetes Federation,2009.
  • 6Walker JD. Diabetes in pregnancy:management of diabetes and its complications from pre-conception to the postnatal period. NICE guideline 63. London, March 2008[J]. Diabet Med, 2008, 25: 1025-1027.
  • 7Hoffman L,Nolan C,Wilson JD,et al.Gestational diabetes mellitus-management guidellnes.The Australasian Diabetes in Pregnancy Society[J].Med J Aust, 1998,169:93-97.
  • 8Canadian Diabetes Association.2008 CDA clinical practiceguidelines for the prevention and management of diabetes in Canada[J].Can J Diabetes,2008,32:S168-180.
  • 9Hadar E,Oats J,Hod M.Towards new diagnostic criteria for diagnosing GDM:the HAPO study[J].J Perinat Med, 2009, 37: 447-449.
  • 10Crowther CA,Hiller JE,Moss JR,et al.Effeet of treatment of gestational diabetes mellitus on pregnancy outeomes[J].N Engl J Med,2005,352:2477-2486.

共引文献1400

同被引文献11

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部